---
title: "Vorinostat - Primary Cutaneous T-Cell Lymphoma"
sidebar: mydoc_sidebar
permalink: db02546-mesh-d016410-1.html
toc: false 
---


Path ID: `DB02546_MESH_D016410_1`
{% include image.html url="images/db02546-mesh-d016410-1.png" file="db02546-mesh-d016410-1.png" alt="db02546-mesh-d016410-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| <a href="https://identifiers.org/MESH:C111237">MESH:C111237 </a> | vorinostat | Drug |
| <a href="https://identifiers.org/UniProt:Q13547">UniProt:Q13547 </a> | Histone deacetylase 1 | Protein |
| <a href="https://identifiers.org/UniProt:Q92769">UniProt:Q92769 </a> | Histone deacetylase 2 | Protein |
| <a href="https://identifiers.org/UniProt:O15379">UniProt:O15379 </a> | Histone deacetylase 3 | Protein |
| <a href="https://identifiers.org/UniProt:Q9UBN7">UniProt:Q9UBN7 </a> | Histone deacetylase 6 | Protein |
| <a href="https://identifiers.org/GO:0070577">GO:0070577 </a> | acetylated histones | ChemicalSubstance |
| <a href="https://identifiers.org/HP:0031377">HP:0031377 </a> | tumor cell proliferation | PhenotypicFeature |
| <a href="https://identifiers.org/GO:0071158">GO:0071158 </a> | cell cycle arrest | BiologicalProcess |
| <a href="https://identifiers.org/GO:0006915">GO:0006915 </a> | apoptosis | BiologicalProcess |
| <a href="https://identifiers.org/MESH:D016410">MESH:D016410 </a> | Primary cutaneous T-cell lymphoma | Disease |
|------------|------|---------|

## Relationships


NOTE: predicates are annotated in <a href="https://github.com/biolink/biolink-model/releases/tag/v1.3.0">Biolink Model (v1.3.0)</a>

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Vorinostat | DECREASES ACTIVITY OF | Histone Deacetylase 1 |
| Vorinostat | DECREASES ACTIVITY OF | Histone Deacetylase 2 |
| Vorinostat | DECREASES ACTIVITY OF | Histone Deacetylase 3 |
| Vorinostat | DECREASES ACTIVITY OF | Histone Deacetylase 6 |
| Histone Deacetylase 1 | INCREASES ABUNDANCE OF | Acetylated Histones |
| Histone Deacetylase 2 | INCREASES ABUNDANCE OF | Acetylated Histones |
| Histone Deacetylase 3 | INCREASES ABUNDANCE OF | Acetylated Histones |
| Histone Deacetylase 6 | INCREASES ABUNDANCE OF | Acetylated Histones |
| Acetylated Histones | DECREASES ACTIVITY OF | Tumor Cell Proliferation |
| Acetylated Histones | POSITIVELY REGULATES | Cell Cycle Arrest |
| Acetylated Histones | POSITIVELY REGULATES | Apoptosis |
| Apoptosis | NEGATIVELY CORRELATED WITH | Primary Cutaneous T-Cell Lymphoma |
| Cell Cycle Arrest | NEGATIVELY CORRELATED WITH | Primary Cutaneous T-Cell Lymphoma |
| Tumor Cell Proliferation | CORRELATED WITH | Primary Cutaneous T-Cell Lymphoma |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB02546#BE0002365](https://go.drugbank.com/drugs/DB02546#BE0002365)
